source
- Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory footholdAt PepMed 2026, a conference focused on peptide medicines, stem cell entrepreneur Chuck Meeker said he expects the FDA to hold a series of roundtables on regenerative therapies before year‑end. He…
- Staggering health insurance premiums force employers to rethink coverage optionsEmployers are confronting staggeringly high health insurance premiums, according to a STAT+ newsletter by reporter Bob Herman. The piece highlights how rising costs are forcing some businesses to r…